Tenax Therapeutics TENX
NASDAQ TENX
$1.98 +0.05 (+2.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tenax Therapeutics (TENX) Selling, General & Administrative (2010 - 2026)

Updated

Tenax Therapeutics (TENX) posted Selling, General & Administrative of $5.93 million for Q2 2026, up 4.6% from $5.67 million a year earlier and up 17.9% from the prior quarter.

Analysis

Tenax Therapeutics (TENX) Selling, General & Administrative (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Tenax Therapeutics was $23.36 million, up 50.3% year-over-year; for FY2025, it came in at $23.71 million, up 249.5% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 34.9% (FY2020 to FY2025).
  • In prior years, Tenax Therapeutics' Selling, General & Administrative was $6.79 million in FY2024 (+35.6%), $5.01 million in FY2023 (-11.8%), $5.68 million in FY2022 (-25.1%) and $7.58 million in FY2021 (+42.8%).
  • Quarterly Selling, General & Administrative has run from a low of $1.04 million in Q2 2023 to a high of $6.48 million in Q3 2025 over five years.
  • On a year-over-year basis, Selling, General & Administrative increased in seven of the last eight quarters, with growth averaging 153.8%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q1 2025, with growth of 358.6%; the weakest was Q3 2022, with a decline of 47.8%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $5.03 million (Q1 2026), $5.91 million (Q4 2025) and $6.48 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Tenax Therapeutics 89.55 Mn 89.55 Mn - 5.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.93 Mn
Mar 31, 2026 5.03 Mn
Dec 31, 2025 5.91 Mn
Sep 30, 2025 6.48 Mn
Jun 30, 2025 5.67 Mn
Mar 31, 2025 5.66 Mn
Dec 31, 2024 2.70 Mn
Sep 30, 2024 1.51 Mn
Jun 30, 2024 1.34 Mn
Mar 31, 2024 1.23 Mn
Dec 31, 2023 1.64 Mn
Sep 30, 2023 1.05 Mn
Jun 30, 2023 1.04 Mn
Mar 31, 2023 1.27 Mn
Dec 31, 2022 1.42 Mn
Sep 30, 2022 1.38 Mn
Jun 30, 2022 1.34 Mn
Mar 31, 2022 1.54 Mn
Dec 31, 2021 2.30 Mn
Sep 30, 2021 2.64 Mn
API Access

Tenax Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TENX&period=max&api_key=YOUR_API_KEY